Ítem
Solo Metadatos

On the need of pharmacoeconomics. Beginning by the principles

Mostrar el registro sencillo de la publicación
dc.creatorVicente-Célis Z.D.spa
dc.creatorSalazar J.C.spa
dc.creatorPineda-Tamayo R.spa
dc.creatorAnaya, Juan-Manuelspa
dc.date.accessioned2020-05-25T23:59:35Z
dc.date.available2020-05-25T23:59:35Z
dc.date.created2011spa
dc.description.abstractHealth expenditures and medication usage have increased dramatically in last years, situation that alerts governments and health authorities, and than can be related with some facts: not standardized medical prescription, excessive gains of the pharmaceutical industry, recent advances in biotechnology related with resource wastefulness, lack of communication between public health entities and clinical physicians and lack of consistent regulatory policies about drug prices. The importance of pharmacoeconomics is based on some aspects: better medical prescription, important role in commercialization and distribution of medicines, capacity of showing a broad and complete scenario of the social and economic impact of diseases, as opening research perspectives in different scientific fields. Within pharmacoeconomical analyses we can found those that show incomes (costs) in monetary units and show outcomes in monetary, natural or utility units: cost minimization, cost benefit, cost utility and cost effectiveness, and also we can found those analyses that study the general panorama of diseases (cost of illness studies). Health costs can be divided into: direct costs (medical and not medical), indirect (economical impact on society) and intangible (related with quality of life of patients and their families). Pharmacoeconomics can lead to a better medical practice, to more efficient health systems and to a more rational usage of resources. These studies are necessary for a proper structure of health programs, as for decision making. The inclusion of health economics concepts within medical and health sciences curricula is also recommended. © 2011 Asociación Colombiana de Reumatologíaspa
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/S0121-8123(11)70053-6
dc.identifier.issn01218123
dc.identifier.issn20279000
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23070
dc.language.isospaspa
dc.publisherAsociacion Colombiana de Reumatologiaspa
dc.relation.citationEndPage202
dc.relation.citationIssueNo. 3
dc.relation.citationStartPage187
dc.relation.citationTitleRevista Colombiana de Reumatologia
dc.relation.citationVolumeVol. 18
dc.relation.ispartofRevista Colombiana de Reumatologia, ISSN:01218123, 20279000, Vol.18, No.3 (2011); pp. 187-202spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85026232657&doi=10.1016%2fS0121-8123%2811%2970053-6&partnerID=40&md5=6c2d4922bb1031d736fd1555dd5ed187spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordBiotechnologyspa
dc.subject.keywordCost benefit analysisspa
dc.subject.keywordCost effectiveness analysisspa
dc.subject.keywordCost minimization analysisspa
dc.subject.keywordCost of illnessspa
dc.subject.keywordCost utility analysisspa
dc.subject.keywordDecision makingspa
dc.subject.keywordDrug costspa
dc.subject.keywordDrug industryspa
dc.subject.keywordDrug usespa
dc.subject.keywordEconomic evaluationspa
dc.subject.keywordHealth care costspa
dc.subject.keywordHealth care planningspa
dc.subject.keywordHealth care policyspa
dc.subject.keywordHealth care qualityspa
dc.subject.keywordHealth programspa
dc.subject.keywordHumanspa
dc.subject.keywordIncomespa
dc.subject.keywordMedical practicespa
dc.subject.keywordPharmacoeconomicsspa
dc.subject.keywordPrescriptionspa
dc.subject.keywordQuality of lifespa
dc.subject.keywordResource managementspa
dc.subject.keywordReviewspa
dc.subject.keywordSocioeconomicsspa
dc.subject.keywordHealth care costsspa
dc.subject.keywordMedical economicsspa
dc.subject.keywordPharmacoeconomicsspa
dc.titleOn the need of pharmacoeconomics. Beginning by the principlesspa
dc.title.TranslatedTitleSobre la necesidad de la farmacoeconomía. Comenzar por los principiosspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos